- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2025
- 143 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- October 2023
- 93 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- July 2023
- 101 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
Europe, United States, ... Europe, United States, Japan
From €3340EUR$3,500USD£2,799GBP
- Book
- April 2023
North America
The Chancroid Test market is a segment of the Infectious Disease Testing industry. It is used to detect the presence of the bacterium Haemophilus ducreyi, which is responsible for the sexually transmitted infection chancroid. The test is typically performed on a sample of fluid taken from the affected area. It is used to diagnose the infection and to monitor the effectiveness of treatment.
The Chancroid Test market is composed of a variety of companies that provide testing services and products. These include diagnostic laboratories, medical device manufacturers, and research and development organizations. These companies offer a range of products and services, such as test kits, laboratory services, and software solutions.
Some companies in the Chancroid Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more
